Publication: 3911

Publication: 3911

Patient-Reported Adverse Events during Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)

URL

Google Scholar

Citation:

Meeting Instance:: ASA 2023
Year:: 2023
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 4016 4342

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA189823, U10CA180868 (NRG)

Corr. Author:
Authors:: Rebecca A. Snyder Amylou C. Dueck Briant Fruth Qian Shi Joleen M. Hubbard Joseph M. Herman Eileen M. O'Reilly Matthew H.G. Katz

Networks:: LAPS-MN026, LAPS-NY016, LAPS-TX035, METROMIN, NORTHWELL

Study: Alliance-A021501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: